share_log

Visa | N-PX: Others

Visa | N-PX: Others

Visa | N-PX：其他
美股SEC公告 ·  08/09 16:08
Moomoo AI 已提取核心信息
The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form S-3 for iBio, Inc. The notice, issued from Washington, D.C., indicates that the form became effective on August 6, 2024, at 4:00 P.M. This form is typically used by companies to register securities for potential future offerings. The SEC's notice confirms that iBio, Inc., which is listed under the Central Index Key (CIK) number 0001420720 and has the file number 333-280680, has met the requirements for this registration statement to become effective.
The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form S-3 for iBio, Inc. The notice, issued from Washington, D.C., indicates that the form became effective on August 6, 2024, at 4:00 P.M. This form is typically used by companies to register securities for potential future offerings. The SEC's notice confirms that iBio, Inc., which is listed under the Central Index Key (CIK) number 0001420720 and has the file number 333-280680, has met the requirements for this registration statement to become effective.
美国证券交易委员会（SEC）已宣布iBio公司Form S-3表格的效力。这个通知是从华盛顿特区发出的，表明该表格于2024年8月6日下午4:00生效。此表通常用于公司注册证券以备未来可能的发行。SEC的通知确认了iBio公司已满足这个注册声明的要求，并列在中央指数密钥（CIK）号码0001420720下，拥有文件编号333-280680。
美国证券交易委员会（SEC）已宣布iBio公司Form S-3表格的效力。这个通知是从华盛顿特区发出的，表明该表格于2024年8月6日下午4:00生效。此表通常用于公司注册证券以备未来可能的发行。SEC的通知确认了iBio公司已满足这个注册声明的要求，并列在中央指数密钥（CIK）号码0001420720下，拥有文件编号333-280680。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息